Loading organizations...
Loading organizations...
Biotechnology company developing antibodies for immuno-oncology.
Alderaan Biotechnology has raised $20.6M across 1 funding round.
Alderaan Biotechnology has raised $20.6M in total across 1 funding round.
Alderaan Biotechnology has raised $20.6M in total across 1 funding round.
Alderaan Biotechnology's investors include Matthieu Coutet, Michele Ollier.
Alderaan Biotechnology has raised $20.6M across 1 funding round. Most recently, it raised $20.6M Series A in January 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 9, 2020 | $20.6M Series A | Matthieu Coutet, Michele Ollier |